SCHEMBL7059867

SCHEMBL7059867

O=C(O)CN1C(=O)[C@@H](N2C(=O)c3ccccc3C2=O)CC[C@H]2C[C@H]21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.45
CA9 Q16790 2/20 0.45
DDB1 Q16531 3/20 0.40
CRBN Q96SW2 3/20 0.40
ALDH1A1 P00352 3/20 0.40
CYP1A2 P05177 2/20 0.40
CHRM2 P08172 1/20 0.40
OPRM1 P35372 1/20 0.40
IKZF3 Q9UKT9 1/20 0.40
TSHR P16473 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
KDM4E B2RXH2 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
HTT P42858 1/20 0.37
CA2 P00918 1/20 0.36
APEX1 P27695 1/20 0.36
MEN1 O00255 1/20 0.35
MAPT P10636 1/20 0.35
AKR1B1 P15121 1/20 0.35
HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7347700 0.85 CA12 (0.43) CA12CA9DDB1CRBNALDH1A1
SCHEMBL7347694 0.85 CA12 (0.43) CA12CA9DDB1CRBNALDH1A1
SCHEMBL7064735 0.78 CA12 (0.41) CA12CA9DDB1CRBNALDH1A1
SCHEMBL7064006 0.78 CA12 (0.41) CA12CA9DDB1CRBNALDH1A1
SCHEMBL7340917 0.77 CA12 (0.39) CA12CA9DDB1CRBNALDH1A1
SCHEMBL7340906 0.77 CA12 (0.39) CA12CA9DDB1CRBNALDH1A1
SCHEMBL18366037 0.76 DDB1 (0.44) DDB1CRBNALDH1A1CYP1A2CHRM2
SCHEMBL8485053 0.75 CA12 (0.41) CA12CA9DDB1CRBNALDH1A1
SCHEMBL8485043 0.75 CA12 (0.41) CA12CA9DDB1CRBNALDH1A1
SCHEMBL1938131 0.75 CA12 (0.41) CA12CA9DDB1CRBNALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0728746-B1 Azepinone compounds useful in the inhibition of ACE and NEP BRISTOL MYERS SQUIBB CO (US) 2003-05-28 EP disclosed
US-5994537-A Process for preparing azepinone compounds useful in the inhibition of ACE and NEP BRISTOL-MYERS SQUIBB CO. (US) 1999-11-30 US disclosed
EP-0728746-A1 Azepinone compounds useful in the inhibition of ACE and NEP BRISTOL-MYERS SQUIBB COMPANY (US) 1996-08-28 EP disclosed